Lobe Sciences (GTSIF) Featured in Coverage of Benzinga’s Healthcare Small Cap Conference
Lobe Sciences (OTC: GTSIF) is a life sciences company focused on psychedelic medicines. The company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness. For more information, visit the company's website at www.lobesciences.com To view IBN’s virtual coverage of Benzinga’s Healthcare Small Cap Conference,…